Inventor · disambiguated record
Michael Bader
Also filed as: BADER MICHAEL · BADER MICHAEL F · BADER MICHAEL P
8 granted patents·8 pending applications·46 citations·filing 1991–2020
82Inventor score
Files withMAX DELBRUECK CENTRUM FUER MOLEKULARE MEDIZIN3WALTHER DIEGO2ARTEMIS PHARMACEUTICALS GMBH1BADER MICHAEL1BADER MICHAEL F1
Top patents by PatentIndex Score
16 records- 0169US10214530B2Xanthine derivatives, their use as a medicament, and pharmaceutical preparations comprising the sameMAX DELBRUECK CENTRUM FUER MOLEKULARE MEDIZIN·Filed 2016·Granted Feb 26, 2019·2 cites·14 claims
- 0263US7049336B2Method for diagnosing neuronal diseases and for treating primary hemostasis deficiencyMAX DELBRUECK CENTRUM·Filed 2001·Granted May 23, 2006·6 cites·8 claims
- 0354US11028104B2Xanthine derivatives, their use as a medicament, and pharmaceutical preparations comprising the sameMAX DELBRUECK CENTRUM FUER MOLEKULARE MEDIZIN·Filed 2020·Granted Jun 8, 2021·0 cites·11 claims
- 0454US5125169AGlove drying apparatus and methodPROTONAUT INC·Filed 1991·Granted Jun 30, 1992·27 cites·14 claims
- 0552US8586054B2Method for modulating, treating and/or preventing metabolic syndrome using MAS-G-protein-coupled receptor agonistsSOUZA DOS SANTOS ROBSON AUGUSTO·Filed 2007·Granted Nov 19, 2013·2 cites·7 claims
- 0650US11337909B2Methods for modulating pigmentation by angiotensin-converting enzyme 2 modulationMAX DELBRUECK CENTRUM FUER MOLEKULARE MEDIZIN HELMHOLTZ GEMEINSCHAFT·Filed 2018·Granted May 24, 2022·0 cites·8 claims
- 0749US10683309B2Xanthine derivatives, their use as a medicament, and pharmaceutical preparations comprising the sameMAX DELBRUECK CENTRUM FUER MOLEKULARE MEDIZIN·Filed 2017·Granted Jun 16, 2020·0 cites·11 claims
- 0848USD398365SSelf defense weaponBADER MICHAEL F·Filed 1996·Granted Sep 15, 1998·9 cites·1 claims
- 0943US2008299550A1Methods and Kits For the Prediction of Therapeutic Success and Recurrence Free Survival In Cancer TherapyBAYER HEALTHCARE AG·Filed 2005·Application pending·0 cites
- 1043US2007299128A1Use of Tryptophan Derivatives for the Specific Cytostatic Treatment of Serotonin-Producing TumorsWALTHER DIEGO·Filed 2007·Application pending·0 cites
- 1143US2014031411A1Gpnmb/osteoactivin as a biomarker and drug target in cardiac diseasesBADER MICHAEL·Filed 2011·Application pending·0 cites
- 1242US2003172879A1Chew toy holding apparatusFiled 2003·Application pending·0 cites
- 1342US2009025097A1Shrna and sirna and mirna expression in a living organism under control of a codon-optimized repressor geneARTEMIS PHARMACEUTICALS GMBH·Filed 2008·Application pending·0 cites
- 1438US2006275759A1Neuronally expressed tryptophane hydroxylase and its useWALTHER DIEGO·Filed 2003·Application pending·0 cites
- 1535US2004097576A1Use of tryptophan derivatives for the specific cytostatic treatment of serotonin-producing tumorsFiled 2002·Application pending·0 cites
- 1630US2004208857A1Use of cells derived from embryonic stem cells for increasing transplantation tolerance and for repairing damaged tissueFiled 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Michael Bader files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →